Professional
Added to YB: 2026-04-08
Pitch date: 2026-04-02
VIMIAN.ST [bullish]
Vimian Group AB (publ)
+1.57%
current return
Author Info
No bio for this author
Company Info
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services.
Market Cap
SEK 1.4B
Pitch Price
SEK 28.65
Price Target
N/A
Dividend
N/A
EV/EBITDA
15.44
P/E
44.28
EV/Sales
3.74
Sector
Health Care Equipment and Supplies
Category
turnaround
Protean Small Cap New Position: Vimian Group AB
VIMIAN.ST (new position): Swedish pet health co w/ broad product offering from pandemic M&A spree. Financial issues fixed via rights issue, ops improving through restructuring. Q4 showed strong earnings quality & cash flow, ignored in market turmoil. Trading low-end post-pandemic range, below where PE sponsor Fidelio (60% owner) bought shares this autumn. Valuation discounts thematic exposure; margin improvement + renewed M&A + sector multiple re-rating = attractive risk/reward.
Read full article (1 min)